Neurocrine Biosciences shares owned by Oppenheimer & Co
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Oppenheimer & Co
from 13F filings
Historical chart of Oppenheimer & Co investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Oppenheimer & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Oppenheimer & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $8.1M | 48k | 168.54 |
| 2026-03-31 | $5.5M | 42k | 131.74 |
| 2025-12-31 | $5.8M | 41k | 141.83 |
| 2025-09-30 | $5.8M | 41k | 140.38 |
| 2025-06-30 | $5.1M | 40k | 125.69 |
| 2025-03-31 | $2.1M | 19k | 110.60 |
| 2024-12-31 | $2.6M | 19k | 136.50 |
| 2024-09-30 | $2.2M | 19k | 115.22 |
| 2024-03-31 | $2.3M | 17k | 137.92 |
| 2023-09-30 | $1.9M | 17k | 112.50 |
| 2023-06-30 | $1.6M | 17k | 94.30 |
| 2023-03-31 | $1.7M | 17k | 101.22 |
| 2022-12-31 | $2.4M | 20k | 119.44 |
| 2022-09-30 | $2.0M | 19k | 106.19 |
| 2022-06-30 | $1.2M | 12k | 97.50 |
| 2022-03-31 | $1.1M | 12k | 93.71 |
| 2021-12-31 | $1.0M | 12k | 85.14 |
| 2021-09-30 | $562k | 5.9k | 95.86 |
| 2021-06-30 | $553k | 5.7k | 97.36 |
| 2021-03-31 | $379k | 3.9k | 97.20 |
| 2020-12-31 | $375k | 3.9k | 95.79 |
| 2020-09-30 | $364k | 3.8k | 96.12 |
| 2020-06-30 | $369k | 3.0k | 122.23 |
| 2020-03-31 | $286k | 3.3k | 86.59 |
| 2019-12-31 | $706k | 6.6k | 107.51 |
| 2019-09-30 | $537k | 6.0k | 90.04 |
| 2019-06-30 | $227k | 2.7k | 84.26 |
| 2019-03-31 | $607k | 6.9k | 88.11 |
| 2018-12-31 | $365k | 5.1k | 71.34 |
| 2018-09-30 | $792k | 6.4k | 122.89 |
| 2018-06-30 | $332k | 3.4k | 98.31 |
| 2018-03-31 | $293k | 3.5k | 82.86 |
| 2013-12-31 | $124k | 13k | 9.39 |